The BioPitch selection committee convened this week and Exiom was selected as one of 16 semi-finalists to compete during the closed-door sessions on the afternoon of Monday, October 21st. BioFlorida received a large number of quality applications this year, and the selection process was very competitive.
Exiom will join 15 other top Life Science companies and present the business to a panel of investors, receive valuable feedback and coaching, and compete for a spot as one of the 4 finalists who will then present at the General Session on the morning of October 22nd. The winner will be announced during the General Session on the 22nd.
Visit http://www.bioflorida.com/ for more information on BioPitch at the 2019 BioFlorida Conference.